DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/qsvmbv/circulating) has announced the addition of the "Circulating Nucleic Acids (CNAs) Based Non-Invasive Cancer Diagnostics: Global Market Report" report to their offering.
The aim of this report was to review recent advances in use of circulating cell-free miRNA, DNA and mRNA as novel biomarkers which can be used for the detection and diagnosis of cancer, and the impact on making the ongoing research closer to clinical application.
The report will also provide a market analysis of the market value, growth rates, market development as well as examining the dynamics and factors influencing the growth and development of this market. This report also looks at the challenges and potential threats facing the industry players, and the factors influencing the market shares of both the major market suppliers and smaller indigenous manufacturers in local markets.
The data collection and forecasting methods used in the preparation of this report are broadly divided into three methods. These are primary data and information gathering, secondary data and information gathering and market share analysis and market forecast prediction. Information and data including estimates on market values, growth rates and market share data were gathered from the methods described and were incorporated into proprietary computer forecasting and market share analysis models.
The forecast model was used to derive market estimates for future years. It incorporates a rate factor, which helps determine the speed with which the market develops, which is similar to that observed for markets for other medical products and is adjusted to match historic data for the market under analysis.
Key Topics Covered:
Chapter 1: Introduction to the Circulating Nucleic Acid Market Report
Chapter 2: Background to Circulating Nucleic Acids
Chapter 3: Cancer: A Statistical Analysis of the Disease Incidence and Prevalence
Chapter 4: CNA Based Cancer Diagnostics Market: Revenue Analysis
Chapter 5: CNA Based Cancer Diagnostics Market: Market Share Analysis
Chapter 6: Company Profiles
- Abbott Laboratories (Abbott Molecular)
- Affymetrix Inc
- Becton Dickinson and Company (BD)
- Beckmann Coulter, Inc (Danaher Corporation)
- Cancer Genetics, Inc
- Dako (Agilent)
- Hologic Gen-Probe
- Ipsogen (Qiagen)
- Myriad Genetics Laboratories
- Novartis Diagnostics
- Ortho-Clinical Diagnostics (The Carlyle Group)
- Oxford Gene Technology (OGT)
- Qiagen N.V.
- Sysmex Corporation
- Thermo Fisher Scientific
- Ventana (Roche)
For more information visit http://www.researchandmarkets.com/research/qsvmbv/circulating